'Pulse On America' Show to Feature Global Pharmatech

'Pulse On America' Show to Feature Global Pharmatech

Thursday, January 11, 2007 8:30 ET

JILIN, China, Jan. 11 /Xinhua-PRNewswire/ -- Global Pharmatech, Inc. (OTC Bulletin Board: GBLP; the ''Company'') a company that develops, manufactures and markets proprietary botanical drugs and dietary supplements, announced that it will be featured in Platinum Television Group's television series, Pulse On America*. The 5 minute long segment will be aired on CNN Headline News through the cable providers in many major U.S. cities. The first airing is on Thursday, January 11, in Detroit, MI. The detailed airing schedule for January 2007 is as follows, with more airing times to follow:

CNN Headline News Detroit Comcast
Thurs. 1/11 @ 10:24 AM
Thurs. 1/11 @ 11:24 AM
Fri. 1/12 @ 8:24 AM
Fri. 1/12 @ 10:24 AM
Fri. 1/12 @ 1:24 PM
Sat. 1/13 @ 10:24 AM
Sat. 1/13 @ 11:24 AM

CNN Headline News
Chicago, IL Comcast Cable
Sat. 1/13 @ 8:24 PM
Sun. 1/14 @ 10:24 AM
Sun. 1/14 @ 1:24 PM
Sun. 1/14 @ 5:24 PM
Sun. 1/14 @ 8:24 PM
Mon. 1/15 @ 10:24 AM
Mon. 1/15 @ 1:24 PM

CNN Headline News
Sarasota-Venice, FL Comcast Cable
Segment 14: Global Pharmatech
Sun. 1/21 @ 3:54 PM
Sun. 1/21 @ 5:54 PM
Sat. 1/27 @ 7:54 AM
Sat. 1/27 @ 8:54 AM
Sat. 1/27 @ 9:54 AM
Sat. 1/27 @ 10:54 AM
Sat. 1/27 @ 12:54 PM

The Company is currently looking for regional distributors for two of its products featured in the show. For more information on the products or distribution of its products, please visit http://www.global-pharmatech.com/ .

* Pulse on America has no direct affiliation with CNN Headline News.

About Global Pharmatech

Global Pharmatech, through its subsidiaries, develops, manufactures and markets proprietary drugs that are based on Traditional Chinese Medicine using modern facilities and advanced R&D technologies. The company offers a full range of start-to-finish biotech services, from research and testing to manufacture and sale of liquid and solid dose products. The Company employs unique proprietary extraction methods and also licenses patents and technologies for botanical/biological drug products. Global Pharmatech's operations are currently based in the People's Republic of China with sales distribution centers in China, Malaysia, Singapore and Indonesia. For more information, please visit http://www.global-pharmatech.com/ .

About Platinum Television Group

Platinum Television Group, founded in 1997, is an independent media production company that specializes in educational programming for national and international markets. Since its inception, PTG producers have helped companies from around the world gain exposure via nationwide broadcast television, cable and satellite distributions systems. For over eight years, PTG has produced magazine-style shows, nationally and internationally televised specials as well as a variety of corporate communications. PTG shows provide information on the latest in cutting edge technology, travel, sports, fashion, business solutions, health and a mix of many other exciting topics. Over the years, PTG's diverse programs have brought forth stories on a variety of companies including Emerson, Burlington, Reebok, Trane, ECR, Honeywell, Mooney, Tyndale House, Hirsch Industries, Optifast/Novartis, Whirlpool, Mag Instrument, Bible League, Citigroup, PECO, DaySpring, Civil Air Patrol, Jim Beam, Casio, Motorola, Hormel, just to name a few. PTG's multi-cultural, multi-talented producers combine decades of experience with cutting-edge technology. Setting industry standards in quality educational programming, PTG's talented staff of over 70 full-time employees produce hundreds of hours of programming each month, reaching viewers around the world.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This news release contains forward-looking statements within the meaning of the ''safe harbour'' provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including our ability to successfully develop and commercialize products, competitive products in our key markets, changes in consumer demand for our products, legislative, regulatory and competitive developments and general economic conditions. Our SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

For more information, please contact:

Zhuojun Li
Investor Relations
Global Pharmatech, Inc.
Tel: +1-905-787-8225
Email: zhuojunli@global-pharmatech.com

Source: Global Pharmatech, Inc.

CONTACT: Zhuojun Li, Investor Relations of Global Pharmatech, Inc.,
+1-905-787-8225, or zhuojunli@global-pharmatech.com

Web Site: http://www.global-pharmatech.com/

-------
Profile: intent